Multicenter, single arm, open label, registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System. Subjects will be followed procedurally to discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of subjects with Immediate Procedural Technical Success
Timeframe: 30 Days
Safety assessment by Number of subjects with absence of Major Adverse Events (MAEs)
Timeframe: 30 Days
Number of subjects with Aneurysm rupture
Timeframe: 5 years
Number of subjects with Conversion to open surgical repair
Timeframe: 5 years
Number of subjects with Endoleak of any type
Timeframe: 5 years
Number of subjects with Clinically significant migration
Timeframe: 5 years
Number of subjects with Aneurysm enlargement
Timeframe: 5 years
Number of incidence with Secondary endovascular procedures
Timeframe: 5 years